ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    ANBL1221
Previous Study | Return to List | Next Study

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01767194
Recruitment Status : Active, not recruiting
First Posted : January 14, 2013
Last Update Posted : April 3, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : February 28, 2019
  Estimated Study Completion Date : February 28, 2019